collectors and maintained a vigorous exchange program.
When Professor Geigy visited the RML in 1948, Dr. Parker promised him a U.S. Public Health Service fellowship for any of Geigy's students interested in the biology of ticks or in the behavior of human and animal pathogens in tick vectors. Although my ongoing thesis research on the development of the relapsing fever spirochete Borrelia duttonii in its tick vector Ornithodoros moubata made me a prime candidate, other colleagues were interested in going to RML. A flip of the coin finally decided that I should apply.
Dr. Parker's death, September 4, 1949 , changed my plans somewhat but not his promise; on December 23, 1951, I reported for duty at RML to study the relationship(s) between spirochetes causing relapsing fever and their argasid tick vectors under the sponsorship of Dr. Gordon E. Davis, a worldrenowned expert on this subject.
Historical Background: Endemic Relapsing Fever
Tick-borne or endemic relapsing fever was first recorded in the United States in 1915 when five persons contracted the disease in Bear Creek Canyon, nized until 1930 when Weller and Graham [15] in Texas reported that cases of relapsing fever seen by them were caused by spirochetes transmitted by the argasid tick Ornithodoros turicata. Five years later, Wheeler et al. [16] showed Ornithodoros hermsi to be a vector in California, and in 1939 Davis [7] speculated that Ornithodoros parkeriwas a likely vector in Wyoming, Montana, Utah, and Washington. Although found infected with spirochetes, this tick (to the present) has never been associated with human relapsing fever; it is often found in burrowing owls' nests and rarely comes in contact with humans.
Not only in North America but also in South and Central America, southern Europe (Spain), Africa, and Asia, numerous ticks of the genus Ornithodoros have been shown to be infected with spirochetes and Throughout the 1940s and still in the early 1950s, tick-borne relapsing fever and its spirochetes were of interest to public health authorities. Although not deadly, relapsing fever was considered a serious and debilitating disease that appeared to be spreading in the southern and western parts of the country. It was felt therefore that public health officials, practicing physicians, and even specialists should have a thorough knowledge of this disease and of the means by which its causative agent is disseminated. Thus, the research activities of Dr. Davis were well supported. One of the many projects we tackled concerned the search for biologic criteria that would allow us to classify and to identify the spirochetes. On the basis of studies carried out since 1936,Davis [17] developed the theory that in the United States each species of Ornithodoros which is a vector of relapsing fever spirochetes carries a spirochete that is tickhost specific, i.e., in no instance has one of the three tick species -O. hermsi, O. turicata, or O. parkeritransmitted the spirochete recovered from either of the other two. On the other hand, a species from one locality never failed to transmit the spirochetes of the same species from another locality.
Although with few exceptions this vector specificity held true for North America, it no longer did for African or Asian tick/spirochete combinations. In fact, in many of these countries, we encountered local specificity to the extent that, for instance, Ornithodoros tholozani from one part of Iran failed to transmit Borrelia persica from another part of that country [18] . Thus, we looked for additional classification criteria, such as the behavior or pathogenicity of spirochetes in newborn animals (mice, rats, voles, guinea pigs, rabbits), only to find that this approach did not work either.
RML was not the only laboratory in which intensive research on the relationship of relapsing fever spirochetes to tick vectors was conducted. To name a few, there were the Pasteur Institute of Iran in Teheran, where Dr. Baltazard [19] Needless to say, I enjoyed my work with Dr. Davis. In fact, I enjoyed it so much that I applied for a second-year fellowship and, when that came to an end, for a position as a visiting scientist. Unfortunately, by that time (December 1953), administrative interest in and support for research on relapsing fevers and tick-borne spirochetes had completely vanished. I never will forget a discussion I had with Dr. Victor Haas, the director of the National Microbiological Institute (as we were then called). "Relapsing fever," he said, "is a disease of the past; it no longer represents a public health problem. We cannot justify financial support for conducting research on an illness that each year may affect a handful of people who can be treated effectively with antibiotics. Considering your plans to stay at RML, I strongly urge you to change to a different field of research." Thus, work on tick-borne spirochetes, for me at least, became a moonlighting job. When Dr. Davis retired in 1956, I inherited his technician, and together we managed to keep going some of the normal as well as spirochete-infected tick colonies. This enabled us through the past 30 years to provide outside agencies with normal or spirochete-infected O.
hermsi, O. turicata, O. parkeri, or even O. moubata.
from Dr. Robert Thompson, a Centers for Disease Control-Epidemiology Intelligence Service (CDC-EIS) officer assigned to the Washington State Health Department, about an outbreak of a febrile illness among boy scouts that he thought might be Colorado tick fever. With a lot of snow still on the ground, I questioned his diagnosis, especially after he told me that the scouts had camped out at Browne Mountain (elevation 3,100 feet) in wooded country about seven miles southwest of Spokane, Washington. At the campsite were two old, poorly kept, and rodentinfested cabins. The older scouts and scoutmasters planned to teach the younger scouts the virtues of roughing it in cold weather; they spent the nights in the cabins while the younger scouts had to sleep in tents. Ten of 20 scouts camping inside and one of 22 sleeping in a tent became ill with feverthat in some instances relapsed as many as three times. While one scout was still in the hospital, I suggested that blood smears be made and examined for relapsing fever spirochetes. They were positive. During a follow-up on-site visit, we collected rodent nesting material from the walls of one cabin and found 18O. hermsi, two of which were positive for spirochetes [25] .
The largest outbreak of tick-borne relapsing fever ever to occur in the Western Hemisphere took place in the summer of 1973 on the North Rim of the Grand Canyon [26] . Sixty-two visitors and Park Service employees who spent one or several nights in log cabins scattered throughout the North Rim Park area contracted the disease. Some investigators believed that this epidemic was closely related to a plague epizootic that had occurred in the area one 935 year earlier and had led to a die-off of the natural rodent hosts of the tick vector O. hermsi.
This may be an ideal point at which to review the number of relapsing fever cases reported since 1959. As summarized in table 2, a total of 345 cases within the distributional area of O. hermsi and 37 cases within that of O. turicata came to the attention of the various state health departments. These figures certainly do not represent a true picture of relapsing fever in the United States. Because in most patients the disease is eventually self-limited, many cases go unrecognized [27] .
Many of the above-mentioned institutions, such as the Pasteur Institute of Iran, the London School of Tropical Medicine and Hygiene, the Tropical Institute in Hamburg, among others, eventually followed RML's decision to "get out of the relapsing fever and spirochete business" (to use a phrase often heard in discussions with administrators). Indeed, for many years, there was little research activity on these subjects. By the end of the 1960s, however, new laboratories with interests not in vector/spirochete relationships but in the immune mechanisms underlying the typical relapsing pattern of the disease had emerged. It had long been speculated that this pattern was related to antigenic phase variations of the spirochetes, which appeared to adapt themselves repeatedly to host antibodies by altering their antigenic profiles.
The exciting research that has been forthcoming during the past years on relapsing fever and tickborne spirochetes was based on the pioneering works of Drs. Coffey and Eveland [28, 29] , who, for the Table 2 . Cases of tick-borne relapsing fever in the United States, 1959-1983. Interested in the immune response in tick-borne relapsing fever, our former director, Dr. Herbert G. Stoenner, initiated a study of antigenic variations of B. hermsii and was able to identify at least 24 different serotypes originating from a single spirochete. Each of these 24 serotypes were also shown to change to seven or more other serotypes. Conversions occurred constantly and were independent of relapses [33] .
In a follow-up study headed by Dr. Alan Barbour, also of RML, each serotype was found to have a protein of different molecular weight, and it was speculated and subsequently proved that a change from the specific protein to another represents the basis for antigenic variation of Borrelia species during relapsing fever [34] .
Dr. Kelly's development of an artifical culture medium for continuous serial passages of certain tick-borne borreliae deserves special mention, for it provided large quantities of spirochetes for immunochemical, molecular, and genetic analyses as well as for serodiagnostic procedures that previously had been hampered by difficulties in obtaining sufficiently large quantities of spirochetes from infected animals. Today, both the IFA and ELISA with cultured spirochetes as antigen appear to be useful in the diagnosis of tick-borne spirochetoses, even though antigenic cross-reactions with other spirochetes may occur, especially in low serum dilutions.
Lyme Disease
Our discovery in the fall of 1981 of a tick-borne spirochete as the long-sought cause of Lyme disease in the United States and of related disorders in EuBurgdorjer rope signaled the beginning of a new era in the research of tick-borne spirochetoses [35, 36] . All of a sudden, clinical investigators, microbiologists, epidemiologists, ecologists, entomologists, and even administrators scrambled for a spot in the "lymelight." No longer did we hear "get out of the spirochete business," for now we had discovered a tick-borne spirochete that at the site of tick-bite causes an expanding annular skin lesion known as erythema chronicum migrans (ECM) in Europe since the beginning of this century [37] . This lesion may be accompanied by fever, headache, stiff neck, and myalgia, now we had discovered a spirochete that causes neurologic disorders such as aseptic meningitis, encephalitis, and neuritis that has been known in Europe since 1922as tick-borne meningopolyneuritis [38] or Bannwarth's syndrome [39] and is often accompanied by paralysis of the facial muscles (Bell's palsy); now we had discovered a spirochete that, within a few weeks to two years after onset of illness, causes migrating musculoskeletal pain in joints, tendons, bursae, muscles,or bones, and arthritis with joint swelling that usually begins months after onset and is characterized by intermittent attacks of swelling and pain, especially in the knees [40] ; now we had found a spirochete that, in about 10070 of patients and from as early as four days to three months after onset, causes fluctuating degrees of atrioventricular block and acute myocarditis, ventricular dysfunction, and cardiomegaly [41] ; now we had found a spirochete capable of spreading transplacentally to the organs of the fetus, causing congenital heart disease and possible death of the infant [42] ; now we had found a spirochete that in Europe, following tick bite, may cause lymphocytoma (lymphadenitis benigna cutis) or acrodermatitis chronica atrophicans [43] .
Many of these clinical manifestations have occurred in Europe for years as entities of unknown cause until we discovered the causative spirochete in 1981.
Lyme disease is a complex, multisystem spirochetosis that affects both children and adults [40] . It was named after the Connecticut community of Lyme, where outbreaks of arthritis had occurred in 1974and 1975that were diagnosed as juvenile rheumatoid arthritis. Thanks to two persistant housewives, Mrs. Polly Murray and Mrs. Judith Mensch of Old Lyme, who questioned this diagnosis, the rheumatology department of Yale University Medical School conducted detailed clinical and epidemi-ologic investigations that eventually led to the description of a new disease entity called Lyme arthritis or Lyme disease. Shortly after the causative spirochete-now called Borrelia burgdorferi [44] was discovered, however, it became apparent that ECM, tick-borne meningoradiculitis, and acrodermatitis chronica atrophicans of Europe are caused by the same, or at least closely related, spirochetes [45] [46] [47] and that these clinical entities may represent various stages of the more complex disease entity called Lyme disease. Even though this term is a misnomer and not appreciated by European investigators because of a specific geographic reference, it does refer to a complex spirochetosis rather to specific clinical manifestations, such as erythema (chronicum) migrans, tick-borne polyneuritis, and lymphadenitis benigna cutis.
In the United States from 1975 through 1979, 512 cases of Lyme disease were diagnosed in 14 predominantly northeastern and midwestern states [48] . In 1982, 49J cases came to the attention of CDC. This number increased to 599 cases in 1983 and to 1,498 cases in 1984 [49] . The number of states reporting this disease has also increased significantly, from 14 in 1979to 20 in 1984, although more than 900/0 of all cases were acquired in Connecticut, Massachusetts, Minnesota, New Jersey, New York, Rhode Island, and Wisconsin. Connecticut and New York, with 483 and 446 cases, respectively, reported the largest number of cases in 1984. As yet, it is not known whether the increase in numbers and widening geographic distribution of cases reflect increased recognition or reporting rather than increased incidence or spread of the vectors and/or spirochetes.
Ticks of the genus Ixodes have been suspected and proved to be vectors. In the United States, the deer tick, Ixodes dammini, from which the initial strain of B. burgdorferi was discovered and isolated, serves as a vector in the northeastern and midwestern states.
In some areas in New York, for instance, up to 100% of adult ticks collected from vegetation have been found to harbor spirochetes (W. B.and J. L. Benach, unpublished observations). In the western part of the country, the western black-legged tick, Ixodes pacificus, has been incriminated as a potential vector. In a recently completed tick/spirochete survey with Dr. Robert Lane from the University of California, Berkeley, and Dr. Robert Gresbrink from the Oregon State Health Division, we were able to confirm this assumption. Of 715 adult ticks from Oregon, 14 (1.9%) were infected, whereas 11 (1.1 %) of 937 972 ticks from Marin, Sonoma, and Mendocino counties in Northern California harbored spirochetes indistinguishable from B. burgdorferi [50] . These figures correlate well with the occurrence of Lyme disease in humans. So far, few cases have been reported from the western United States, whereas in the Northeast and Midwest the disease is considerably more prevalent.
Spirochetes indistinguishable from B. burgdorferi have been detected also in Amblyomma americanum [51] , Dermacentor variabilis [52] , Rhipicephalus sanguineus [53] , Haemaphysalis leporispalustris [52] [36] . As yet, little is known about the natural history of the Lyme disease spirochete, particularly its source for infecting ticks. So far, spirochetes have been recovered from the blood of white-tailed deer (Odocoileus virginianus) [54] , a raccoon (Procyon lotor) [55] , white-footed mice (Peromyscus leucopus) [54] [55] [56] , and from the liver of a passerine bird (Cadtharusfuscescens) [57] . The white-footed mouse appears to be a preferred host of immature I. dammini and is considered a potential spirochetal reservoir [58] . Although these animals, as fas as we know, are not adversely affected by the Lyme disease spirochete, dogs have been shown to be susceptible and will suffer lameness from inflammation in one or more joints [59] [60] [61] . Spirochetes identical to B. burgdorferi have been isolated from the blood of a Doberman Pinscher suffering stiffness in all four limbs [59] .
Present Research
The discovery of the causative agent of Lyme disease and related disorders in 1981 has opened the doors for intensive clinical, epidemiologic, and ecologic research as attested to by the plethora of papers published during the past two years. With the help of sophisticated immunochemical and molecular technology, it suddenly has become possible to gain insight into the complex biology of tick-borne spirochetes. .Relapsing fevers and their causative agents also have again become a prime target for research, and, as one discovery follows another, new fields to our vision are opened. Ornithodoros coriaceus is considered the vector of an as yet unknown agent causing epizootic bovine abortion (EBA) in rangeland cattle within the distributional area of O. coriaceus [63] . In California alone annual losses from EBA vary from 5070 to 60% in individual herds, at a cost of $5 to $15 million. Chlamydiae have been proposed as the cause of this disease [64] , but vaccines prepared from this agent did not protect cattle in areas where EBA is enzootic [65] .
In a recent paper we suggest that the O. coriaceus spirochete may be causally related to EBA because of the high percentage of infected ticks in recognized EBA areas [62] . Also, the fact that prophylactic treatment of cattle with chlortetracycline reduces the abortion rates under field conditions indicates that an antibiotic-sensitive organism, such as a spirochete, may be the abortifacient agent. Finally, it is well known [66] that pregnant woman infected with relapsing fever frequently abort -a phenomenon known to occur also in Lyme disease, as discussed previously.
In 1948, I started my career as a medical entomologist with a study of the development of B. duttonii spirochetes in O. moubataticks [67] . Although during the past 37 years I ventured into various fields of arthropod-borne pathogens, I always managed to keep up my interest in tick-borne spirochetoses. The discovery of the Lyme disease agent undoubtedly has led to a renaissance of interest in this subject. Having had the privilege to contribute to this exciting development is a most rewarding feeling as I am about to join the ranks of retired persons.
